Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeynep Irem Ozay

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
JAMA Network Open|May 12, 2025
Race, Ethnicity, and Tumor Genomic Testing in Prostate CancerZeynep Irem Ozay, Neeraj Agarwal
JCO Oncology Practice|February 27, 2025
Challenges in the Management of Advanced Prostate CancerZeynep Irem Ozay, Umang Swami, Neeraj Agarwal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2024
Targeting the FGFR Pathway in Patients with Advanced Solid TumorsChadi Hage Chehade, Zeynep Irem Ozay, Neeraj Agarwal
Med (New York, N.Y.)|February 15, 2025
On-treatment PSA kinetics as a potential biomarker: Guiding personalized treatment in metastatic hormone-sensitive prostate cancerZeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Precision and Combination Strategies for Immune Checkpoint Inhibitors in Prostate CancerNicolas Sayegh, Zeynep Irem Ozay, Tian Zhang, et al.
European Urology|September 24, 2024
Correlating Prostate-specific Antigen Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment: Refining Predictive and Prognostic BiomarkersChadi Hage Chehade, Zeynep Irem Ozay, Neeraj Agarwal, et al.
JCO Precision Oncology|December 18, 2024
Assessing Nectin-4 as a Predictive Biomarker in Urothelial Carcinoma and Other Genitourinary MalignanciesZeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal, et al.
Expert Opinion on Pharmacotherapy|August 30, 2024
Talazoparib for the treatment of prostate cancerArshit Narang, Chadi Hage Chehade, Zeynep Irem Ozay, et al.
Therapeutic Advances in Medical Oncology|March 26, 2026
Antibody-drug conjugates in prostate cancer: current landscape and future directionsZeynep Irem Ozay, Chadi Hage Chehade, Georges Gebrael, et al.
European Urology|March 12, 2025
T-cell Engagers in Prostate CancerChadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
JAMA Network Open|May 12, 2025
Race, Ethnicity, and Tumor Genomic Testing in Prostate CancerZeynep Irem Ozay, Neeraj Agarwal
JCO Oncology Practice|February 27, 2025
Challenges in the Management of Advanced Prostate CancerZeynep Irem Ozay, Umang Swami, Neeraj Agarwal
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2024
Targeting the FGFR Pathway in Patients with Advanced Solid TumorsChadi Hage Chehade, Zeynep Irem Ozay, Neeraj Agarwal
Med (New York, N.Y.)|February 15, 2025
On-treatment PSA kinetics as a potential biomarker: Guiding personalized treatment in metastatic hormone-sensitive prostate cancerZeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2025
Precision and Combination Strategies for Immune Checkpoint Inhibitors in Prostate CancerNicolas Sayegh, Zeynep Irem Ozay, Tian Zhang, et al.
European Urology|September 24, 2024
Correlating Prostate-specific Antigen Dynamics with Outcomes of Lutetium-177-PSMA-617 Treatment: Refining Predictive and Prognostic BiomarkersChadi Hage Chehade, Zeynep Irem Ozay, Neeraj Agarwal, et al.
JCO Precision Oncology|December 18, 2024
Assessing Nectin-4 as a Predictive Biomarker in Urothelial Carcinoma and Other Genitourinary MalignanciesZeynep Irem Ozay, Chadi Hage Chehade, Neeraj Agarwal, et al.
Expert Opinion on Pharmacotherapy|August 30, 2024
Talazoparib for the treatment of prostate cancerArshit Narang, Chadi Hage Chehade, Zeynep Irem Ozay, et al.
Therapeutic Advances in Medical Oncology|March 26, 2026
Antibody-drug conjugates in prostate cancer: current landscape and future directionsZeynep Irem Ozay, Chadi Hage Chehade, Georges Gebrael, et al.
European Urology|March 12, 2025
T-cell Engagers in Prostate CancerChadi Hage Chehade, Zeynep Irem Ozay, Micah Ostrowski, et al.
Pageof 3